Showing results (4891-4900 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|December 8, 2020
A Randomized Phase II Study of AGS-16C3F Versus Axitinib in Previously Treated Patients with Metastatic Renal Cell CarcinomaChristian Kollmannsberger, Toni K Choueiri, Daniel Y C Heng, et al.
The Oncologist|December 21, 2020
Benefit-Risk Summary of Nivolumab for the Treatment of Patients with Unresectable Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma After Prior Fluoropyrimidine- and Platinum-Based ChemotherapyLorraine Pelosof, May Tun Saung, Martha Donoghue, et al.
The Oncologist|January 4, 2021
A Phase II Study of Apatinib in Patients with Chemotherapy-Refractory Esophageal Squamous Cell Carcinoma (ESO-Shanghai 11)Li Chu, Yun Chen, Qi Liu, et al.
The Oncologist|May 6, 2022
Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network StudyLouis Garnier, Chrystelle Vidal, Olivier Chinot, et al.
The Oncologist|July 30, 2021
Clinical Outcomes, Treatment Toxicity, and Health Care Utilization in Older Adults with Aggressive Non-Hodgkin LymphomaP Connor Johnson, Alisha Yi, Nora Horick, et al.
The Oncologist|July 27, 2021
Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS StudyJohn R Zalcberg, Michael C Heinrich, Suzanne George, et al.
The Oncologist|August 1, 2021
Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single-Dose Administration Under Fasting Conditions in Prostate CancerLisa M Cordes, Keith T Schmidt, Cody J Peer, et al.
The Oncologist|April 12, 2013
Association of anthracycline-related cardiac histological lesions with NADPH oxidase functional polymorphismsAlmudena Cascales, Francisco Pastor-Quirante, Beatriz Sánchez-Vega, et al.
The Oncologist|April 12, 2013
Antiangiogenic therapies for advanced hepatocellular carcinomaKeeran R Sampat, Bert O'Neil
The Oncologist|February 23, 2013
Evaluation of patient enrollment in oncology phase I clinical trialsDiane A J van der Biessen, Merlijn A Cranendonk, Gaia Schiavon, et al.
Pageof 571